• KOLs Community
    • Early
    • Early Discharge
    • Enrico Bernardi
    • Enrico Bernardi

      Enrico Bernardi

      Acute and Emergency Department, Ca’ Foncello Hospital, Treviso, Italy | University of Padova, Legnaro, PD, Italy | Dept of Emergency Medicine, ULSS 2 Marca Trevigiana – ...



      KOL Resume for Enrico Bernardi


      Acute and Emergency Department, Ca’ Foncello Hospital, Treviso, Italy


      Department of Emergency Medicine, ULSS n.7, Via Brigata Bisagno 4, 31015 Conegliano (Treviso), Italy


      Department of Emergency Medicine, ULSS n.7, Conegliano, TV, Italy




      Dipartimento di Matematica, Università di Bologna



      Enrico Bernardi: Influence Statistics

      Sample of concepts for which Enrico Bernardi is among the top experts in the world.
      Concept World rank
      triple involutive #1
      triple characteristics cauchy #2
      class hyperbolic operators #7
      triple characteristics #15
      hyperbolic operators #19
      counting variable #25
      operators triple #26
      score normotensive #30
      chronic raas inhibitors #30
      double characteristics #43
      1year mortality life #48
      multinational treatment #51
      bova score #52
      planned population #52
      bova risk #53
      hotpe #55
      3month recurrence #56
      acts pulmonary #57
      life early discharge #61
      bova #61
      predefined interim analysis #69
      eq5d5l scale #85
      life acts #85
      improvement p00001 #86
      entire trial population #89
      hyperbolic operator #94
      acute lowrisk #96


      Prominent publications by Enrico Bernardi

      KOL-Index: 9033

      BACKGROUND: The effect of chronic use of renin-angiotensin-aldosterone system (RAAS) inhibitors on the severity of COVID-19 infection is still unclear in patients with hypertension. We aimed to investigate the association between chronic use of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs) and COVID-19-related outcomes in hypertensive patients.

      METHODS: A single-center study was conducted on 133 consecutive hypertensive subjects presenting to ...

      Known for Raas Inhibitors | Hypertensive Patients | Covid19 Infection | Clinical Deterioration | Oxygen Therapy
      KOL-Index: 6360

      AIMS: To investigate the efficacy and safety of early transition from hospital to ambulatory treatment in low-risk acute PE, using the oral factor Xa inhibitor rivaroxaban.

      METHODS AND RESULTS: We conducted a prospective multicentre single-arm investigator initiated and academically sponsored management trial in patients with acute low-risk PE (EudraCT Identifier 2013-001657-28). Eligibility criteria included absence of (i) haemodynamic instability, (ii) right ventricular dysfunction or ...

      Known for Early Discharge | Risk Pulmonary | Inhibitor Rivaroxaban | Ambulatory Treatment | Ventricular Dysfunction
      KOL-Index: 6005

      BACKGROUND: The Bova score has shown usefulness in the identification of intermediate-high risk patients with acute pulmonary embolism (PE), but lacks prospective validation. The aim of this study was to prospectively validate the Bova score in different settings from the original derivation cohort.

      METHODS: Consecutive, normotensive patients with acute PE recruited at 13 academic or general hospitals were stratified, using their baseline data, into the three Bova risk stages (I-III). ...

      Known for Bova Score | Normotensive Patients | Pulmonary Embolism | Adverse Outcomes | Primary Point
      KOL-Index: 5325

      INTRODUCTION: Early discharge of patients with acute low-risk pulmonary embolism requires validation by prospective trials with clinical and quality-of-life outcomes.

      METHODS: The multinational Home Treatment of Patients with Low-Risk Pulmonary Embolism with the Oral Factor Xa Inhibitor Rivaroxaban (HoT-PE) single-arm management trial investigated early discharge followed by ambulatory treatment with rivaroxaban. The study was stopped for efficacy after the positive results of the ...

      Known for Early Discharge | Quality Life | Pulmonary Embolism | Pemb Qol | Oral Anticoagulation
      KOL-Index: 4644

      BACKGROUND: Tocilizumab blocks pro-inflammatory activity of interleukin-6 (IL-6), involved in pathogenesis of pneumonia the most frequent cause of death in COVID-19 patients.

      METHODS: A multicenter, single-arm, hypothesis-driven trial was planned, according to a phase 2 design, to study the effect of tocilizumab on lethality rates at 14 and 30 days (co-primary endpoints, a priori expected rates being 20 and 35%, respectively). A further prospective cohort of patients, consecutively ...

      Known for Tocilizumab Patients | Antibodies Monoclonal | Covid19 Pneumonia | Single Arm | Cov2 Treatment
      KOL-Index: 1090
      Known for Cauchy Problem | Hyperbolic Operators | Triple Characteristics
      KOL-Index: 661
      Known for Hyperbolic Operators | Double Characteristics
      KOL-Index: 633
      Known for Cauchy Problem | Hyperbolic Operator
      KOL-Index: 280

      Spatial variability represents a challenge for viticulture. Variable-rate fertilization is a promising technology to manage different vigor and yield zones within the. In this study, on-the-go variable rate fertilization system was implemented and tested, based on commercial spectral sensors. GreenSeeker Normalized Difference Vegetation Index (NDVI) sensor was mounted in front of a tractor and connected to the electronic control unit of a variable rate spreader. Fertilizer rate was based ...

      Known for Variable Rate
      KOL-Index: 215
      Known for Cauchy Problem

      Key People For Early Discharge

      Top KOLs in the world
      Eric David Peterson
      atrial fibrillation myocardial infarction heart failure
      Stephan W Windecker
      aortic valve myocardial infarction eluting stents
      Ulla Waldenström
      birth center early pregnancy maternal age
      Henrik Kehlet
      knee arthroplasty epidural analgesia chronic pain
      Robert M Califf
      myocardial infarction thrombolytic therapy heart failure
      Daniel B Mark
      heart failure myocardial infarction catheter ablation

      Enrico Bernardi:Expert Impact

      Concepts for whichEnrico Bernardihas direct influence:Early discharge,  Raas inhibitors,  Bova score,  Hyperbolic operators,  Cauchy problem,  Deep vein,  Normotensive patients,  Risk pulmonary.

      Enrico Bernardi:KOL impact

      Concepts related to the work of other authors for whichfor which Enrico Bernardi has influence:Pulmonary embolism,  Risk stratification,  Cauchy problem,  Outpatient treatment,  Enzyme inhibitors,  Raas blockers,  Acei arb.



      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

      Acute and Emergency Department, Ca’ Foncello Hospital, Treviso, Italy | University of Padova, Legnaro, PD, Italy | Dept of Emergency Medicine, ULSS 2 Marca Trevigiana – Ospedale di Treviso, Treviso, Italy | Department of Emergency Medicine, ULSS n.7,

    Download on the App StoreGet it on Google Play

    Copyright © 2023 - KOL means Key Opinion Leaders .

    KOL does not provide medical advice, diagnosis or treatment.